Mobile development framework

Ipsos: Growth acceleration

Retrieved on: 
Thursday, October 26, 2023

Our activities in the fields of brand perception measurement and analysis, optimizing marketing and market positioning expenses, innovation, as well as qualitative surveys all deliver sustained growth.

Key Points: 
  • Our activities in the fields of brand perception measurement and analysis, optimizing marketing and market positioning expenses, innovation, as well as qualitative surveys all deliver sustained growth.
  • Finally, our activity with doctors and patients is improving from quarter to quarter, with nearly 6% organic growth in Q3.
  • The clear acceleration we are seeing in Q3 will continue and intensify over the rest of the year.
  • We confirm our organic growth target of between 3 and 4%, alongside an operating margin of around 13% – demonstrating the resilience of our model, our ability to control costs and improve our gross margin.

Ipsos: delayed revenue but positive momentum on the order book

Retrieved on: 
Thursday, April 20, 2023

Our Ipsos.Digital platform also continues to expand rapidly with 36% growth in Q1.

Key Points: 
  • Our Ipsos.Digital platform also continues to expand rapidly with 36% growth in Q1.
  • Our citizens research for government and the public sector decreased by 13%, reflecting the end of the large Covid contracts in March last year.
  • We have identified interesting acquisition targets in the public affairs, healthcare and technology sectors, particularly in the United States.
  • An update on our plan will be presented at the Investor Day on June 14.

Solid growth

Retrieved on: 
Thursday, October 27, 2022

In particular, double-digit growth is experienced in the Service Lines that focus on measuring and analyzing brand growth and expression.

Key Points: 
  • In particular, double-digit growth is experienced in the Service Lines that focus on measuring and analyzing brand growth and expression.
  • After massive growth during the 2020-21 period spurred by large scale Covid-testing programmes in Europe, our work among citizens has fallen back in 2022.
  • However, the underlying business excluding Covid contracts records a double-digit growth, confirming the need for governments to better understand citizens expectations and behaviours in an uncertain and inflationary world.
  • Finally, our work with doctors and patients has seen moderate growth in 2022, impacted by an unfavorable base effect after a rapid expansion during the pandemic.

First quarter 2022: Performing well

Retrieved on: 
Thursday, April 21, 2022

That said, compared to Q1 2020 and Q1 2019, the citizens segment has shown 39% and 52% organic growth, respectively.

Key Points: 
  • That said, compared to Q1 2020 and Q1 2019, the citizens segment has shown 39% and 52% organic growth, respectively.
  • Profitability is up compared to the first quarter of 2021 and in line with the objectives for the year.
  • The generation of free cash flow from operations has similarly increased and is also in line with expectations.
  • The company is part of the SBF 120 and Mid-60 indices and is eligible for the Deferred Settlement Service (SRD).

Third quarter results - Proven Growth

Retrieved on: 
Thursday, October 21, 2021

The continued growth in 2021 is a testament to the structural strengthening of this business line, independent of the follow-up to the covid-19 pandemic.

Key Points: 
  • The continued growth in 2021 is a testament to the structural strengthening of this business line, independent of the follow-up to the covid-19 pandemic.
  • The work with "Doctors and patients", which had experienced a slight progression in 2020, recorded strong growth in 2021.
  • Thus, 2022 could be the year of a return to growth for the Customers segment.
  • The company continued its investment in platforms in the third quarter with the acquisition of Infotools announced on September 15.